Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BRTX

BioRestorative Therapies (BRTX)

BioRestorative Therapies Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BRTX
DateTimeSourceHeadlineSymbolCompany
28/02/202523:57Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
28/02/202501:45GlobeNewswire Inc.BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic PainNASDAQ:BRTXBioRestorative Therapies Inc
27/02/202512:15GlobeNewswire Inc.BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline UpdateNASDAQ:BRTXBioRestorative Therapies Inc
26/02/202500:00GlobeNewswire Inc.BioRestorative to Provide a Positive FDA Update on Clinical PipelineNASDAQ:BRTXBioRestorative Therapies Inc
21/02/202500:30GlobeNewswire Inc.BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:43Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:39Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
20/02/202508:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
19/02/202523:54Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
11/02/202508:29Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
11/02/202500:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
10/02/202523:00GlobeNewswire Inc.BRTX-100 Front and Center at ORS 2025NASDAQ:BRTXBioRestorative Therapies Inc
06/12/202409:37Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
05/12/202422:45GlobeNewswire Inc.BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
15/11/202404:33Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
13/11/202423:00GlobeNewswire Inc.BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical DataNASDAQ:BRTXBioRestorative Therapies Inc
13/11/202408:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BRTXBioRestorative Therapies Inc
13/11/202408:05GlobeNewswire Inc.BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:BRTXBioRestorative Therapies Inc
07/11/202408:43Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BRTXBioRestorative Therapies Inc
07/11/202408:37Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BRTXBioRestorative Therapies Inc
07/11/202408:25Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:BRTXBioRestorative Therapies Inc
06/11/202423:00GlobeNewswire Inc.BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research SymposiumNASDAQ:BRTXBioRestorative Therapies Inc
06/11/202408:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BRTXBioRestorative Therapies Inc
05/11/202423:10GlobeNewswire Inc.BioRestorative Therapies Receives Expanded Tissue License from New York State Department of HealthNASDAQ:BRTXBioRestorative Therapies Inc
31/10/202422:00GlobeNewswire Inc.BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease ProgramNASDAQ:BRTXBioRestorative Therapies Inc
 Showing the most relevant articles for your search:NASDAQ:BRTX